Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT01096992 · COMPLETED
Trial details
- NCT number
- NCT01096992
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-19
- Primary completion
- 2017-03-31
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.